Surveillance and Diagnostic Algorithm for Hepatocellular Carcinoma Proposed by the Liver Cancer Study Group of Japan: 2014 Update
Authors:
- Masatoshi KudoMasatoshi Kudo
- Osamu MatsuiOMOsamu Matsui
- Namiki IzumiNINamiki Izumi
- Hiroko IijimaHIHiroko Iijima
- Masumi KadoyaMKMasumi Kadoya
- Yasuharu ImaiYIYasuharu Imai
- on behalf of the Liver Cancer Study Group of JapanOJon behalf of the Liver Cancer Study Group of Japan
- 1 November 2014
- journal article
- review article
- Published by S. Karger AG in Oncology
- Vol. 87 (Suppl. 1) , 7-21
Abstract
Surveillance and diagnostic algorithms for hepatocellular carcinoma (HCC) have already been described in guidelines published by the American Association for the Study of Liver Diseases (AASLD), the European Association for the Study of the Liver and the European Organisation for Research and Treatment of Cancer (EASL-EORTC), and the Japan Society of Hepatology (JSH), but the content of these algorithms differs slightly. The JSH algorithm mainly differs from the other two algorithms in that it is highly sophisticated and considers the functional imaging techniques of gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced MRI (EOB-MRI) and Sonazoid contrast-enhanced ultrasound (CEUS) to be very important diagnostic modalities. In contrast, the AASLD and EASL-EORTC algorithms are less advanced and suggest that a diagnosis be made based solely on hemodynamic findings using dynamic CT/MRI and biopsy findings. A consensus meeting regarding the JSH surveillance and diagnostic algorithm was held at the 50th Liver Cancer Study Group of Japan Congress, and a 2014 update of the algorithm was completed. The new algorithm reaffirms the very important role of EOB-MRI and Sonazoid CEUS in the surveillance and diagnosis of liver cancer and is more sophisticated than those currently used in the United States and Europe. This is now an optimized algorithm that can be used to diagnose early-stage to classical HCC easily and highly accurately.Keywords
This publication has 106 references indexed in Scilit:
- Gadoxetic Acid Disodium-Enhanced Magnetic Resonance Imaging for the Detection of Hepatocellular Carcinoma: A Meta-AnalysisPLOS ONE, 2013
- Alpha-fetoprotein-L3: Useful or Useless for Hepatocellular Carcinoma?Liver Cancer, 2013
- Non-hypervascular hypointense nodules detected by Gd-EOB-DTPA-enhanced MRI are a risk factor for recurrence of HCC after hepatectomyJournal of Hepatology, 2013
- Role of Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid-Enhanced Magnetic Resonance Imaging in the Management of Hepatocellular Carcinoma: Consensus at the Symposium of the 48th Annual Meeting of the Liver Cancer Study Group of JapanOncology, 2013
- HCC-to-liver contrast on arterial-dominant phase images of EOB-enhanced MRI: comparison with dynamic CTMagnetic Resonance Imaging, 2013
- Detectability of hepatocellular carcinoma by gadoxetate disodium‐enhanced hepatic MRI: Tumor‐by‐tumor analysis in explant liversJournal of Magnetic Resonance Imaging, 2012
- Hepatocellular carcinoma in a North American population: Does hepatobiliary MR imaging with Gd‐EOB‐DTPA improve sensitivity and confidence for diagnosis?Journal of Magnetic Resonance Imaging, 2012
- Assessment of Gd-EOB-DTPA-enhanced MRI for HCC and dysplastic nodules and comparison of detection sensitivity versus MDCTJournal of Gastroenterology, 2012
- Comparison of International Guidelines for Noninvasive Diagnosis of Hepatocellular CarcinomaLiver Cancer, 2012
- Management of Hepatocellular Carcinoma: An Update ΔσHepatology, 2011